Enzyme-mediated modification of fibrin for tissue engineering
AssigneeCalifornia Institute of Technology
InventorsJeffrey Hubbell, Jason Schense, Andreas Zisch, Heike Hall
Life of this patent
Estimating the term…
Abstract
Matrices covalently bound to bidomain peptides or proteins, produced recombinantly or synthetically, contain a transglutaminase substrate domain and a bioactive factor. The bioactive factor is preferably a growth factor, such as VEGF, growth factors from the TGF-β superfamily, PDGF, human growth hormone, IGF, and ephrin. Particularly preferred growth factors are TGF-β1, BMP 2; VEGF121 and PDGF AB. The matrix material is crosslinkable, and may form a gel. These compositions are useful for tissue repair and regeneration.
Claims17
A composition comprising a matrix and a recombinant bidomain protein or peptide having an amino acid sequence that comprises a transglutaminase substrate domain and a bioactive factor, wherein the protein or peptide is covalently bound to the matrix by the transglutaminase substrate domain.
A method of attaching a bioactive factor to a matrix, comprising
- recombinantly producing a biodomain peptide or protein comprising a bioactive factor and a transglutaminase substrate domain;
- and
- exposing the matrix to a transglutaminase to covalently couple the bidomain peptide or protein to the matrix and crosslink the matrix.
Dependencies are inferred from the claim text.